Search

everythinglearnresearchcommunity

for

Search:↓

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

Tea tree oil cream effectively reduces hair growth.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Epitestosterone may act as a weak antiandrogen and can inhibit an enzyme involved in testosterone metabolism.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Cannabinoid and steroid-based drugs could be new treatments for Tourette syndrome, but more research is needed to confirm their effectiveness and safety.

Apremilast may help treat hair loss in alopecia areata.

Gingerol may help treat chronic graft-versus-host disease by improving immune cell balance.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

Alkaloids help fight influenza in animals but need more research for human use.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

New treatments for severe alopecia areata, especially JAK inhibitors, are recommended as first-line therapy.

The treatment was ineffective in humans.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Switching JAK inhibitors or using dupilumab may help some alopecia areata patients who don't respond well to initial treatments.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.